Desko et al., 2009 - Google Patents
Effects of N-glycosylation on the activity and localization of GlcNAc-6-sulfotransferase 1Desko et al., 2009
View HTML- Document ID
- 11336858271367498360
- Author
- Desko M
- Gross D
- Kohler J
- Publication year
- Publication venue
- Glycobiology
External Links
Snippet
Abstract N-Acetylglucosamine-6-sulfotransferase-1 (GlcNAc6ST-1) is a Golgi-resident glycoprotein that is responsible for sulfation of the l-selectin ligand on endothelial cells. Here, we report the sites at which GlcNAc6ST-1 is modified with N-linked glycans and the …
- 230000000694 effects 0 title abstract description 41
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ni et al. | The lysosomal trafficking of acid sphingomyelinase is mediated by sortilin and mannose 6‐phosphate receptor | |
| Cho et al. | Galectin-1, a β-Galactoside-binding lectin in Chinese hamster ovary cells: II. Localization and biosynthesis (∗) | |
| Ju et al. | Regulation of protein O-glycosylation by the endoplasmic reticulum–localized molecular chaperone Cosmc | |
| Opat et al. | Medial Golgi but not late Golgi glycosyltransferases exist as high molecular weight complexes: role of luminal domain in complex formation and localization | |
| Li et al. | Post-translational Modifications of Recombinant P-selectin Glycoprotein Ligand-1 Required for Binding to P-and E-selectin (∗) | |
| Wu et al. | Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder | |
| Sanchez et al. | The Na, K-ATPase α4 isoform from humans has distinct enzymatic properties and is important for sperm motility | |
| Martı́nez-Pomares et al. | Cell-specific glycoforms of sialoadhesin and CD45 are counter-receptors for the cysteine-rich domain of the mannose receptor | |
| Liu et al. | Mammalian GPI-anchor modifications and the enzymes involved | |
| Khoder-Agha et al. | Assembly of B4GALT1/ST6GAL1 heteromers in the Golgi membranes involves lateral interactions via highly charged surface domains | |
| Matsuzono et al. | Functional domain mapping of peroxin Pex19p: interaction with Pex3p is essential for function and translocation | |
| Tsuiji et al. | Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell–cell adhesion | |
| Engelmann et al. | Transmembrane and secreted MUC1 probes show trafficking-dependent changes in O-glycan core profiles | |
| Rind et al. | A severe human metabolic disease caused by deficiency of the endoplasmatic mannosyltransferase hALG11 leads to congenital disorder of glycosylation-Ip | |
| Shauchuk et al. | N-glycosylation of the human β1, 4-galactosyltransferase 4 is crucial for its activity and Golgi localization | |
| Fujimura et al. | LARGE2 facilitates the maturation of α-dystroglycan more effectively than LARGE | |
| Zhang et al. | Identification of topological determinants in the N-terminal domain of transcription factor Nrf1 that control its orientation in the endoplasmic reticulum membrane | |
| Esmail et al. | N‐linked glycosylation of a subunit isoforms is critical for vertebrate vacuolar H+‐ATPase (V‐ATPase) biosynthesis | |
| Huang et al. | GnT1IP-L specifically inhibits MGAT1 in the Golgi via its luminal domain | |
| Shan et al. | Polypeptide N-acetylgalactosaminyltransferase 18 non-catalytically regulates the ER homeostasis and O-glycosylation | |
| Niu et al. | Structure of the transmembrane protein 2 (TMEM2) ectodomain and its apparent lack of hyaluronidase activity | |
| Kitazume-Kawaguchi et al. | The relationship between ST6Gal I Golgi retention and its cleavage-secretion | |
| Bazan et al. | Lysine at position 329 within a C-terminal dilysine motif is crucial for the ER localization of human SLC35B4 | |
| Marron-Terada et al. | The two mannose 6-phosphate binding sites of the insulin-like growth factor-II/mannose 6-phosphate receptor display different ligand binding properties | |
| Breloy et al. | Initiation of mammalian O-mannosylation in vivo is independent of a consensus sequence and controlled by peptide regions within and upstream of the α-dystroglycan mucin domain |